TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 3 | 2 | 2 | 10 | 8 | 3 | 5 |
| P | %wins | 100 | 100 | 50 | 50 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/23 18:34 | 11/20/23 | VIGL | Vigil Neuroscience, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Magovcevic-Liebisch Ivana | MA | DO | P,CEO | P | 15 | 3.75 | 0 | 4 | 2 | 208 | D | ||||||||||||||
5/4/22 07:00 | 5/2/22 | VIGL | Vigil Neuroscience, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Magovcevic-Liebisch Ivana | MA | DO | P,CEO | P.m | 18 | 3.68 | 0 | 5 | 3 | 204 | D | ||||||||||||||
11/17/16 16:53 | 11/16/16 | AGTC | Applied Genetic Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Magovcevic Ivana | FL | D | P | 29 | 9.63 | 2 | 3 | New | 3 | D | -58 | -41 | -38 | -37 | -7 | 25 | 30 | -5 | 5 | 3 | -9 | -16 | |||
3/17/11 13:29 | 3/16/11 | DYAX | Dyax Corp | DE | Health | Biolab | Commercial Physical & Biologi | Magovcevic Ivana | MA | O | EVP Corp | P | 8 | 1.50 | 1 | 5 | New | 5 | D | -38 | -64 | -35 | -31 | -25 | -16 | -6 | 0 | 1 | 0 | 13 | 35 | 8 | 3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |